1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. MONTE ROSA THERAPEUTICS INC
Monte Rosa Therapeutics Inc XNAS: GLUE

Monte Rosa Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Mid-range Performer
about

Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutica...

Read More
16.28 0.24 (1.50%)
36.83% Fall from 52W High
33,428.1
XNAS Volume

XNAS 13 Mar, 2026 9:33 AM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Monte Rosa Therapeutics Inc is on 20 Mar 2026 for the purpose of Monte Rosa Therapeutics Inc Fourth Quarter Earnings Results for 2025 See details
Durability score
High Financial Strength
61.1 / 100
Valuation Score
Mid Valuation
38.0 / 100
Momentum Score
Technically Neutral
57.2 / 100
Mid-range Performer These stocks have strong quality. Their reasonable financials and technicals make them potentially attractive to investors View Similar Embed DVM
Analyst Price Target
33
1Yr Price target upside is 104%
6 analysts

8

S

10

W

5

O

1

T

SWOT Analysis

Monte Rosa Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..